Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies

Transplantation Proceedings

Volumn 36, Issue 1, 2004, Pages 134-136

  Toz H ^a   Sen S ^a   Sezis M ^a   Duman, S ^a   Ozkahya M ^a   Ozbek S ^a   Hoscoskun C ^a   Atabay, G ^a   Ok, E ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MICROEMULSION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0842281683     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.11.056     Document Type: Conference Paper

References (12)

1. Pirsch J.D., Miller J., Deierhoi M.H. A comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation. 63:1997;977.
2. Halloran P.F., Melk A., Barth C. Rethinking chronic allograft nephropathy the concept of accelerated senescence . J Am Soc Nephrol. 10:1999;167.
3. Paul L.C. Chronic allograft nephropathy an update . Kidney Int. 56:1999;783.
4. Benediktsonn H. International standardization of criteria for the histological diagnosis of renal allograft rejection the Banff working classification of kidney transplant pathology . Kidney Int. 45:1993;411.
5. Paul L.C., Sijpkens Y.W. Renal transplant protocol biopsies a surrogate biomarker for late graft loss . Transplantation. 69:2000;1771.
6. Seron D., Moreso F., Bover J., et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int. 51:1997;310.
7. Seron D., Moreso F., Ramon J.M., et al. Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation. 69:2000;1849.
8. Legendre C., Thervet E., Skhiri H., et al. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation. 65:1998;1506.
9. Nickerson P., Jeffery J., Gough J., et al. Identification of clinical and histopathological risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol. 9:1998;482.
10. DN, Nickerson P, Jeffery JR, McKenna RM, Grimm PC, Gough J: Rush protocol biopsies in renal transplantation: research tool or clinically useful? Curr Opin Nephrol Hypertens 7:691, 1998.
11. Solez K., Vincenti F., Filo R.S. Histopathological findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine. Transplantation. 66:1998;1736.
12. Isoniemi H.M., Krogerus L., von Willebrand E., et al. Histopathological findings in well-functioning, long-term renal allografts. Kidney Int. 41:1992;155.